Masimo develops, manufactures and markets non-invasive patient monitoring products. Its Masimo Signal Extraction Technology provides measure-through motion and low perfusion pulse oximetry to measure oxygen saturation levels in arterial blood. In 2012, the company launched the first ever iPhone-enabled pulse oximeter. Masimo also offers remote monitoring and clinician notification solutions based on the Masimo SET algorithms. This software- based technology is incorporated into a variety of product platforms depending on customers’ specifications.